According to Horizon Therapeutics 's latest financial reports the company's total assets are $9.29 B. A companyโs total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Year | Total assets | Change |
---|---|---|
2022-12-31 | $9.11 B | 5.03% |
2021-12-31 | $8.67 B | 42.9% |
2020-12-31 | $6.07 B | 36.89% |
2019-12-31 | $4.43 B | 6.99% |
2018-12-31 | $4.14 B | -0.47% |
2017-12-31 | $4.16 B | -2.93% |
2016-12-31 | $4.29 B | 39.95% |
2015-12-31 | $3.06 B | 170.31% |
2014-12-31 | $1.13 B | 349.19% |
2013-12-31 | $0.25 B | 30.21% |
2012-12-31 | $0.19 B | 91.92% |
2011-12-31 | $0.10 B | -37.48% |
2010-12-31 | $0.16 B | 1868.65% |
2009-12-31 | $8.21 M | -45.08% |
2008-12-31 | $14.95 M |
Company | Total assets | differencediff. | Country |
---|---|---|---|
Pfizer PFE | $226.50 B | 2,335.82% | ๐บ๐ธ USA |
Amgen AMGN | $97.15 B | 944.81% | ๐บ๐ธ USA |
Merck MRK | $106.67 B | 1,047.20% | ๐บ๐ธ USA |
AstraZeneca AZN | $101.11 B | 987.45% | ๐ฌ๐ง UK |
Dr. Reddy's RDY | $4.47 B | -51.84% | ๐ฎ๐ณ India |